LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced side-effect hemoglobin compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reduced volume formulation of glatiramer acetate and methods...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reducing adhesion

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reducing adhesion

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing agent for reductive alkylation of glycopeptide antibiot

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing axon degeneration with proteasome inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing axon degeneration with proteasome inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reducing bacterial content in water

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Reducing muscle fatigue

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing post-prandial fluctuations in plasma concentrations of

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reducing post-prandial fluctuations in plasma concentrations of

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reducing post-prandial fluctuations in plasma concentrations of

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reducing postoperative astigmatism

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reducing pyrophosphate deposition with calcium antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reducing reperfusion injury with 1,3-dihydro-4-methyl-5-(4-methy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Silicon containing doai

Reducing sebum spreading

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Reducing tetracycline resistance in living cells

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Reducing tetracycline resistance in living cells

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

Reducing tetracycline resistance in living cells